>Brivekimig1_1
DVQLVESGGGVVQPGGSLRLSCAASGRTFSSIYAKG-WFRQAPGKEREFVAAISRSGRSTSYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTALYYCAAVGGATTVTASEW----------DYWGQGTLVTVSS
>Brivekimig1_2
EVQLVESGGGVVQPGGSLRLSCAASGRTFSSIYAKG-WFRQAPGKEREFVAAISRSGRSTSYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTALYYCAAVGGATTVTASEW----------DYWGQGTLVTVSS
>Brivekimig2
EVQLVESGGGVVQPGGSLRLSCAASGFTFRSFGMS--WVRQAPGKGPEWVSSISGSGSDTLYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTALYYCTIGGSL------------------SRSSQGTLVTVSS
>Caplacizumab
EVQLVESGGGLVQPGGSLRLSCAASGRTFSYNPMG--WFRQAPGKGRELVAAISRTGGSTYYPDSVEGRFTISRDNAKRMVYLQMNSLRAEDTAVYYCAAAGVRAEDGRVRTLPSEY-----TFWGQGTQVTVSS
>Enristomig_1
EVQLLESGGGEVQPGGSLRLSCAASGGIFAIKPIS--WYRQAPGKQREWVSTTT-SSGATNYAESVKGRFTISRDNAKNTLYLQMSSLRAEDTAVYYCNVF---------------------EYWGQGTLVTVKP
>Enristomig_2
EVQLLESGGGEVQPGGSLRLSCAASGFSFSINAMG--WYRQAPGKRREFVAAIE-SGRNTVYAESVKGRFTISRDNAKNTVYLQMSSLRAEDTAVYYCGLLKGNRVVSPSV-----------AYWGQGTLVTVKP
>Envafolimab
QVQLVESGGGLVQPGGSLRLSCAASGKMSSRRCMA--WFRQAPGKERERVAKLLTTSGSTYLADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAADSFEDPTCTLVTSSGAF-----QYWGQGTLVTVSS
>Erfonrilimab_2
QVQLVESGGGLVQPGGSLRLSCAASGYIYSAYCMG--WFRQAPGKGLEGVAAIYIGGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAADVIPTETCLGGSWSGPF-----GYWGQGTLVTVSS
>Gacovetug
QVQLQESGGGLVQPGGSLRLSCTASGSISSINAMG--WYRQAPGSKREFVAHIT-NTGVTEFADSVKGRFTISRDNAKTTVDLQMNSLKPEDTAVYYCAATDWGTLLIKGI-----------DHWGKGTQVTVSS
>Gefurulimab_1
EVQLVESGGGLVKPGGSLRLSCAASGRPVSNYAAA--WFRQAPGKEREFVSAIN-WQKTATYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAAVFRVVAPKTQYDY---------DYWGQGTLVTVSS
>Gefurulimab_2
EVQLVESGGGLVQPGGSLRLSCAASGRAHSDYAMA--WFRQAPGQEREFVAGIGWSGGDTLYADSVRGRFTNSRDNSKNTLYLQMNSLRAEDTAVYYCAARQGQYIYSSMRSDSY-------DYWGQGTLVTVSS
>Gocatamig1
EVQLVESGGGLVQPGNSLRLSCAASGFTFSKFGMS--WVRQAPGKGLEWVSSISGSGRDTLYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYCTIGGSL------------------SVSSQGTLVTVSS
>Gocatamig2
EVQLVESGGGLVQPGGSLTLSCAASSSSVSLLSLA--WYRQAPGKKRELVAGIS-DDGSIVYMDSVKGRFTISRDNAKNSVYLQMNSLRAEDTAVYYCYAYSWITRS---------------PYWGQGTLVTVSS
>Gontivimab_1
DVQLVESGGGLVQAGGSLSISCAASGGSLSNYVLG--WFRQAPGKEREFVAAINWRGDITIGPPNVEGRFTISRDNAKNTGYLQMNSLAPDDTAVYYCGAGTPLNPGAYIYDWSY-------DYWGRGTQVTVSS
>Gontivimab_2
EVQLVESGGGLVQAGGSLSISCAASGGSLSNYVLG--WFRQAPGKEREFVAAINWRGDITIGPPNVEGRFTISRDNAKNTGYLQMNSLAPDDTAVYYCGAGTPLNPGAYIYDWSY-------DYWGRGTQVTVSS
>Isecarosmab_1
DVQLVESGGGVVQPGGSLRLSCAASGRTVSSYAMG--WFRQAPGKEREFVAGISRSAERTYYVDSLKGRFTISRDNSKNTVYLQMNSLRPEDTALYYCAADLDPNRIFSREEY---------AYWGQGTLVTVSS
>Isecarosmab_2
EVQLVESGGGVVQPGNSLRLSCAASGFTFSSFGMS--WVRQAPGKGLEWVSSISGSGSDTLYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTALYYCTIGGSL------------------SRSSQGTLVTVSS
>Letolizumab
EVQLLESGGGLVQPGGSLRLSCAASGFTFNWELMG--WARQAPGKGLEWVSGIEGPGDVTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVKVGKDAKS---------------DYRGQGTLVTVSS
>Lofacimig_1
QVQLVESGGGSVQAGGSLRLSCAASGHTYSSNYCMA-WFRQAPGKEREGVAAIY-SDGSTSYADSVKGRFTISKDNSKNTLYLQMNSLRAEDTAVYYCAATAYEGSWTGKQPLCLLYEY---TYWGQGTLVTVSS
>Lofacimig_2
QVQLVESGG-SVQAGGSLRLSCTASEFTFDDSDMA--WYRQAPGNECELVSTIT-SDGGTYYADSVKGRFTISQDNSKNTMYLQMNSLRAEDTAVYYCAADQWGSAEGDCTSSYPG------GYWGQGTLVTVSS
>Lunsekimig1_1
DVQLVESGGGVVQPGGSLRLSCAASGRTFSSYRMG--WFRQAPGKEREFVAALSGDGYSTYTANSVKGRFTISRDNSKNTVYLQMNSLRPEDTALYYCAAKLQYVSGWSYDY----------PYWGQGTLVTVSS
>Lunsekimig1_2
EVQLVESGGGVVQPGGSLRLSCAASGFTFNNYAMK--WVRQAPGKGLEWVSSITTGGGSTDYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTALYYCANVPFGYYSEHFSGLSF-------DYRGQGTLVTVSS
>Lunsekimig2_1
EVQLVESGGGVVQPGGSLRLSCAASGSGFGVNILY--WYRQAAGIERELIASIT-SGGITNYVDSVKGRFTISRDNSENTMYLQMNSLRAEDTGLYYCASRNIFDGT---------------TEWGQGTLVTVSS
>Lunsekimig3
EVQLVESGGGVVQPGGSLRLSCAASGFTFADYDYDIGWFRQAPGKEREGVSCISNRDGSTYYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTALYYCAVEIHCDDYGVENFDF--------DPWGQGTLVTVSS
>Ozekibart
EVQLLESGGGEVQPGGSLRLSCAASGLTFPNYGMG--WFRQAPGKEREFVSAIYWSGGTVYYAESVKGRFTISRDNAKNTLYLQMSSLRAEDTAVYYCAVTIRGAATQTWKY----------DYWGQGTLVTVKP
>Ozoralizumab_1
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYWMY--WVRQAPGKGLEWVSEINTNGLITKYPDSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYCARSPSG------------------FNRGQGTLVTVSS
>Ozoralizumab_2
EVQLVESGGGLVQPGNSLRLSCAASGFTFSSFGMS--WVRQAPGKGLEWVSSISGSGSDTLYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYCTIGGSL------------------SRSSQGTLVTVSS
>Podentamig1_1
EVQLVESGGGLVQPGRSLTLSCAASTNIFSISPYG--WYRQAPGKQRELVAAI--HGTSTLYADSVKGRFTISRDNAKNSIYLQMNSLRPEDTALYYCNKVPWGDYHPGN------------VYWGQGTQVTVSS
>Porustobart
EVQLVESGGGLIQPGGSLRLSCAVSGFTVSKNYMS--WVRQAPGKGLEWVSVVY-SGGSKTYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAVPHSPSSF-------------DIWGQGTMVTVSS
>Produvofusp
QVQLVESGGGLVKPGGSLRLSCAASGRTFSSYAMG--WFRQAPGKEREFVSAISGSGGSTYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAADLGDGSWVDYVNAEPYEY----DYWGQGTLVTVSS
>Pumitamig2
EVQLQESGGGLVQPGGSLRLSCAASGFTFSSYWMY--WLRQAPGKGLEWVSSINSDSSSTYYRDSVKGRFTISRDNAKNTLYLQMNSLKSEDTAVYYCAKDPGG------------------YAKGQGTQVTVSS
>Rimteravimab
DVQLVESGGGLVQPGGSLRLSCAASGRTFSEYAMG--WFRQAPGKEREFVATISWSGGATYYTDSVKGRFTISRDNAKNTVYLQMNSLRPEDTAVYYCAAAGLGTVVSEWDYDY--------DYWGQGTLVTVSS
>Simridarlimab
QVQLQESGGGLVQPGGSLRLSCAASAYTISRNSMG--WFRQAPGKGLEGVAAIE-SDGSTSYSDSVKGRFTISLDNSKNTLYLEMNSLRAEDTAVYYCAAPKVGLGPRTALGHLAFMTLPALNYWGQGTLVTVSS
>Sonelokimab1_1
DVQLVESGGGLVQPGGSLRLSCAASGRTFSSYVVG--WFRQAPGKEREFIGAISGSGESIYYAVSEKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCTADQEFGYLRFGRS----------EYWGQGTLVTVSS
>Sonelokimab2
EVQLVESGGGLVQPGGSLRLSCAASGRTYDAMG----WLRQAPGKEREFVAAISGSGDDTYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCATRRGLYYVWDANDY---------ENWGQGTLVTVSS
>Surovatamig
EVQLVESGGGLVQPGGSLRLSCAASGFSFSDFWMS--WVRQAPGKGLEWVATISQAGSEKDYVDSVKGRFTISRDNAKKSLYLQMNSLRAEDTAVYYCASGVYSF-----------------DYRGQGTLVTVSS
>Tarperprumig_1
QVQLVESGGGLVKPGGSLRLSCAASGRPVSNYAAA--WFRQAPGKEREFVSAIN-WQKTATYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAAVFRVVAPKTQYDY---------DYWGQGTLVTVSS
>Tarperprumig_2
EVQLLESGGGLVQPGGSLRLSCAASGRISSIIHMA--WFRQAPGKERELVSEIS-RVGTTVYADSVKGRFTISRDNSKNTLYLQMNSLKPEDTAVYYCNALQYEKHGGA-------------DYWGQGTLVTVSS
>Tixentamig
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMH--WVRQVPGKGLVWVSRISSDASRTIYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARGEDHDILTGY------------PIRGQGTTVTVSS
>Vobarilizumab_1
EVQLVESGGGLVQPGGSLRLSCAASGSVFKINVMA--WYRQAPGKGRELVAGII-SGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYCAFITTESDYDLGR-----------RYWGQGTLVTVSS
>IGHV3-7*01
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMS--WVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-21*08
EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMN--WVRQAPGKGLEWVSSIS-SSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-23*01
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMS--WVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAK-----------------------------------
>IGHV3-23*03
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMS--WVRQAPGKGLEWVSVIYSGGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAK-----------------------------------
>IGHV3-23*04
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMS--WVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAK-----------------------------------
>IGHV3-23*05
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMS--WVRQAPGKGLEWVSAIYSSGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAK-----------------------------------
>IGHV3-43*02
EVQLVESGGGVVQPGGSLRLSCAASGFTFDDYAMH--WVRQAPGKGLEWVSLISGDGGSTYYADSVKGRFTISRDNSKNSLYLQMNSLRTEDTALYYCAK-----------------------------------
>IGHV3-53*01
EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMS--WVRQAPGKGLEWVSVIY-SGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-66*01
EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMS--WVRQAPGKGLEWVSVIY-SGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-66*03
EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMS--WVRQAPGKGLEWVSVIY-SCGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-69-1*01
EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMN--WVRQAPGKGLEWVSSIS-SSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-74*01
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMH--WVRQAPGKGLVWVSRINSDGSSTSYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCAR-----------------------------------
>IGHV3-74*03
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMH--WVRQAPGKGLVWVSRINSDGSSTTYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCAR-----------------------------------
